I assume management have done a cost benefit analysis, but it seems they will be undercutting by price and volume from their chemist customers. If long term sales are canabolized from the chemists then they may commit the shelf space to another up and coming, higher margin brand.
Hopefully the pie grows as the margins drop.
- Forums
- ASX - By Stock
- BWX
- Forecast: Busy
Forecast: Busy, page-82
Featured News
Add BWX (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.99M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BWX (ASX) Chart |
Day chart unavailable
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online